Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Pharmacology   Volumes    Volume 13  Issue 2
Resistance to SSRIs: Role of serotonin
E. Calcagno, R .W. Invernizzi
Pages: 71 - 79
Number of pages: 9
Current Topics in Pharmacology
Volume 13  Issue 2

Copyright © 2009 Research Trends. All rights reserved

Antidepressant drugs have greatly improved the outcome of depression but approximately 50% of patients do not respond to these drugs. Serotonin (5-HT) is a key neurotransmitter in depression. A number of studies suggested an association between the response to selective 5-HT reuptake inhibitors (SSRIs), the mainstays in the treatment of depression, and variants in genes modulating central 5-HT neurotransmission such as the 5-HT transporter, 5-HT receptors, the recently discovered isoform of tryptophan hydroxylase (TPH-2), the enzyme responsible for the synthesis of 5-HT in the brain. The focus of the present paper is to summarize recent mouse studies that have boosted new interest in the role of 5-HT in the resistance to antidepressant drugs and the mechanisms involved. The results indicate that an impaired 5-HT transmission contribute to the lack of effect of SSRIs in the forced swimming test, a widely used procedure to assess the antidepressant potential of compounds and suggest that 5-HT precursor loading and prevention of the activation of negative feedback mechanisms controlling 5-HT neurons may be useful to improve the response to SSRIs.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms